| abstract |
ABSTRACT A therapeutic agent for osteoporosis, comprising an azepine compound of the formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient, a method for treating osteoporosis comprising administering said compound and a use of said compound for the production of a therapeutic agent for osteoporosis. In the above formula, each symbol is as defined in the following. Ar is aryl or heteroaryl; X is an oxygen atom or a sulfur atom: W is -N(R36)-, -O- or -S-; Ring Q is selected from the following group , , and X and Y combinedly form =N-N=C(R6)-, =N-C(R5)=C(R6)-, =C(R5)-N=C(R6)-, =N-O-CO- or -N-N(R5)-CO-. |